FAVI, EVALDO
 Distribuzione geografica
Continente #
NA - Nord America 5.390
AS - Asia 4.954
EU - Europa 3.428
SA - Sud America 538
AF - Africa 132
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.487
Nazione #
US - Stati Uniti d'America 5.180
SG - Singapore 1.720
CN - Cina 1.463
IT - Italia 952
HK - Hong Kong 488
RU - Federazione Russa 488
GB - Regno Unito 430
BR - Brasile 424
VN - Vietnam 379
DE - Germania 361
FR - Francia 289
SE - Svezia 231
IN - India 213
IE - Irlanda 212
BD - Bangladesh 184
CA - Canada 146
NL - Olanda 127
ID - Indonesia 122
FI - Finlandia 79
TR - Turchia 70
JP - Giappone 56
KR - Corea 52
AT - Austria 48
CI - Costa d'Avorio 42
DK - Danimarca 42
AR - Argentina 39
AU - Australia 39
ZA - Sudafrica 33
IQ - Iraq 30
MX - Messico 29
ES - Italia 28
EG - Egitto 27
PH - Filippine 27
TW - Taiwan 26
CH - Svizzera 23
UA - Ucraina 23
EC - Ecuador 17
CO - Colombia 16
PL - Polonia 16
MY - Malesia 15
BE - Belgio 12
JM - Giamaica 12
RO - Romania 12
TH - Thailandia 12
CL - Cile 11
PK - Pakistan 11
UY - Uruguay 11
UZ - Uzbekistan 11
VE - Venezuela 11
CZ - Repubblica Ceca 9
IR - Iran 9
NP - Nepal 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
JO - Giordania 7
NG - Nigeria 7
PT - Portogallo 7
AZ - Azerbaigian 6
BG - Bulgaria 6
MA - Marocco 6
LV - Lettonia 5
BB - Barbados 4
ET - Etiopia 4
KE - Kenya 4
KW - Kuwait 4
LT - Lituania 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
OM - Oman 4
PE - Perù 4
SV - El Salvador 4
BS - Bahamas 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
LB - Libano 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
IL - Israele 2
IS - Islanda 2
KZ - Kazakistan 2
MU - Mauritius 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
Totale 14.471
Città #
Singapore 905
Ashburn 697
Hong Kong 439
San Jose 362
Milan 347
Chandler 339
Southend 328
Dallas 256
Council Bluffs 214
Dublin 208
Princeton 206
Fairfield 201
Beijing 162
Frankfurt am Main 157
Los Angeles 153
Hefei 135
Lauterbourg 125
Santa Clara 125
Ho Chi Minh City 117
Bengaluru 105
Houston 102
Wilmington 101
Buffalo 90
Jakarta 89
Hanoi 88
New York 87
Seattle 85
Ann Arbor 71
Des Moines 71
Cambridge 64
Guangzhou 61
Moscow 61
Toronto 60
Woodbridge 60
Istanbul 56
Munich 55
Rome 55
Washington 55
Boardman 51
Cangzhou 49
Chicago 49
Shanghai 48
Dearborn 46
Helsinki 43
Abidjan 42
Tokyo 38
Nanjing 37
Columbus 36
Nuremberg 36
Seoul 36
São Paulo 35
Atlanta 33
Phoenix 33
The Dalles 32
Fremont 27
Jinan 25
Bühl 23
Montreal 23
Brooklyn 22
Vienna 22
Dong Ket 20
Johannesburg 20
San Diego 20
Turku 19
London 18
Naples 18
Tianjin 18
Shenyang 17
Lappeenranta 16
Medford 16
Philadelphia 16
Redwood City 16
Chennai 15
Hangzhou 15
Turin 15
Wuhan 15
Fuzhou 14
Manila 14
Sydney 14
Berlin 13
Silver Spring 13
Haiphong 12
Mumbai 12
Zhengzhou 12
Changsha 11
Da Nang 11
Falls Church 11
Kuala Lumpur 11
Monza 11
Parma 11
San Francisco 11
Shenzhen 11
Amsterdam 10
Baghdad 10
Bari 10
Belo Horizonte 10
Biên Hòa 10
Brussels 10
Charlotte 10
Detroit 10
Totale 8.224
Nome #
Bone effects and safety of one year denosumab therapy in a cohort of renal transplanted patients: An observational monocentric study 765
Characterization of an in vitro model to study the possible role of polyomavirus BK in prostate cancer 362
Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation 319
Human cytomegalovirus-related gastrointestinal disease after kidney transplantation: A systematic review 297
Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer 270
Allograft artery mycotic aneurysm after kidney transplantation: A case report and review of literature 254
Viral Genomic Characterization and Replication Pattern of Human Polyomaviruses in Kidney Transplant Recipients 226
Impact of Donor Age on Clinical Outcomes of Primary Single Kidney Transplantation From Maastricht Category-III Donors After Circulatory Death 222
Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice? 218
Longitudinal study of human polyomaviruses viruria in kidney transplant recipients 197
Allograft Vesicoureteral Reflux after Kidney Transplantation 197
Hypothermic machine perfusion in kidney transplantation: back to the future? 190
Treatment options for localised renal cell carcinoma of the transplanted kidney 186
Hesitancy toward the Full COVID-19 Vaccination among Kidney, Liver and Lung Transplant Recipients in Italy 181
Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS 179
Infected nonhealing wound in a kidney transplant recipient : successful treatment with topical homologous platelet-rich gel 179
Post-Transplant Diabetes Mellitus in Kidney-Transplanted Patients: Related Factors and Impact on Long-Term Outcome 178
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 175
Bone effect and safety of one-year denosumab therapy in a Cohort of renal transplanted patients : an observational monocentric study 165
Thirty-Six Consecutive Kidney Transplants in Recipients with Atypical Hemolytic Uremic Syndrome: A Single-Centre Experience 158
Epidemiology, Clinical Characteristics, Diagnostic Work Up, and Treatment Options of Leishmania Infection in Kidney Transplant Recipients: A Systematic Review 157
Prevalence and Risk Factors of Abnormal Glucose Metabolism and New-Onset Diabetes Mellitus after Kidney Transplantation: A Single-Center Retrospective Observational Cohort Study 157
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 156
Origin and pattern of human polyomaviruses replication after kidney transplantation: a prospective observational study 154
Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period 152
New-onset diabetes after kidney transplantation 152
Origin and Pattern of Human Polyomaviruses Replication after Kidney Transplantation : A Prospective Study 149
Systematic review of ablative therapy for the treatment of renal allograft neoplasms 148
Cytomegalovirus Disease in Renal Transplanted Patients : Prevalence, Determining Factors, and Influence on Graft and Patients Outcomes 148
DCD kidney transplantation in Italy: past, present, and future 146
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy : a Single-Center Experience 144
Intra-operative Postperfusion Micronephrolithotomy for Renal Allograft Lithiasis: A Case Report 143
Adipose-derived stem/stromal cells in kidney transplantation: Status quo and future perspectives 140
Causes of late transplant failure in cyclosporine-treated kidney allograft recipients 139
Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects 137
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 136
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 132
Update on current and potential application of extracellular vesicles in kidney transplantation 130
In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication 128
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation 125
Evolution of Causes of Mortality in Renal Transplantation in the Last 10 Years 124
Tacrolimus-Associated Terminal Ileitis After Kidney Transplantation, Mimicking Crohn Disease: A Case Report 123
Bortezomib-containing multimodality treatment for antibody-mediated rejection with anti-HLA and anti-AT1R antibodies after kidney transplantation 123
Association of Serum Levels and Immunohistochemical Labelling of Des-Gamma-Carboxy-Prothrombin in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma 122
Salus Populi Suprema Lex : Considerations on the initial response of the United Kingdom to the SARS-CoV-2 pandemic 121
Casual factors and clinical impact of urinary tract infections in renal transplanted patients: An observational retrospective study 119
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept 117
Multidisciplinary management of complicated bilateral renal artery aneurysm in a woman of childbearing age 117
Preimplantation biopsy predicts delayed graft function, glomerular filtration rate and long-term graft survival of transplanted kidneys 117
High levels of parathyroid hormone after one month of renal transplantation are related to long term graft loss 116
OUTCOMES OF KIDNEY TRANSPLANTATION AT THE EPICENTRE OF THE COVID-19 PANDEMIC: THE EXPERIENCE OF THE OSPEDALE MAGGIORE POLICLINICO 113
Outcomes of Patients Receiving a Kidney Transplant or Remaining on the Transplant Waiting List at the Epicentre of the COVID-19 Pandemic in Europe: An Observational Comparative Study 112
Mycophenolic Acid Reduces BK Polyomavirus Replication in an In Vitro Model of Renal Tubular Epithelial Cells Infection 110
Physical inactivity: A modifiable risk factor for morbidity and mortality in kidney transplantation 106
La dialisi peritoneale rappresenta la tecnica sostitutiva di prima scelta per i pazienti candidabili al trapianto di rene? [Is peritoneal dialysis the first-choice renal replacement therapy for patients waiting for a kidney transplant?] 105
LCP-tacrolimus-induced posterior reversible encephalopathy syndrome in a high-immunological-risk kidney transplant recipient 104
De novo malignancies after organ transplantation: Focus on viral infections 104
Outcomes of Kidney Transplantation at the Epicenter of the Covid-19 Pandemic: The Experience of the Ospedale Maggiore Policlinico 104
Improving Clinical Governance of Kidney Transplantation: Review of a Ruling and of the Clinical Governance Process in the United Kingdom 101
Editorial: Assessing the value and cost of Organ Donation and Transplantation (ODT) 100
Abdominal aortic aneurysm in renal transplant recipients 100
Early Onset Mycoplasma spp. Infection After Kidney Transplantation: A Systematic Review 97
Same Incision for Simultaneous Laparoscopic Hand-Assisted Native Nephrectomy Contralateral to the Site of the Kidney Transplant 97
Spontaneous renal allograft rupture complicated by urinary leakage : Case report and review of the literature 96
Clinical Outcomes of Prophylactic and Therapeutic Plasmapheresis in Adult Deceased-Donor Kidney Transplant Recipients With Primary Focal Segmental Glomerulosclerosis 95
Inferior long-term outcomes for kidney transplant recipients with an immunologically mediated primary renal disease 94
Longitudinal Study Investigating Characteristics of Human Polyimaviruses Infection after Kidney Transplantation 93
Advancing immunosuppression in liver transplantation: A narrative review 92
Utility and safety of early allograft biopsy in adult deceased donor kidney transplant recipients 92
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 89
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 88
KIDNEY TRANSPLANTATION IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME: THE OSPEDALE MAGGIORE POLICLINICO EXPERIENCE OVER 35 YEARS 88
Incidence and outcomes of polyomavirus infection in 639 kidney transplant recipients : Are high immunological risk characteristics more relevant than specific induction or maintenance immunosuppressive regimens? 88
Long-Term Outcomes of Primary Kidney Transplant from Expanded Criteria Maastricht Category 3 DCD Donors: A Single-Centre Observational Study 85
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 83
De novo single kidney transplantation from Maastricht category III donation after circulatory death donors aged 60 years or over: is it safe? 83
Living-Donor Kidney Transplant in a Patient With Type B Mayer-Rokitansky-Küster-Hauser Syndrome, Reconstructed Vagina, and Abnormal Pelvic Vessels : A Case Report 83
BK POLYOMAVIRUS INFECTION AFTER KIDNEY TRANSPLANTATION: 5-YEAR RESULTS OF A SINGLE-CENTRE OBSERVATIONAL STUDY 83
Effect of Ethnicity on Recipient Characteristics, Kidney Transplant Provision and Outcomes in a High-Volume National Health Service Hospital. 82
Single Kidney Transplantation from DCD Maastricht Category 3 Donors >= 60 Years: Is It Safe? 81
3 Years Outcomes in a Randomized Trial Evaluating Everolimus Plus CNI Reduction in Kidney Transplant Recipients 81
Conversion from Prograf to Advagraf in stable kidney transplant recipients : Better renal function after 3-year follow-up 79
Initial Experiences with Rapid Access, Self-Sealing, Polycarbonate Urethane Nanofiber Vascular Grafts for Hemodialysis 78
Mini-invasive living donor nephrectomy using the hand-assited laparoscopic technique: our first experience 77
Who is at risk in living kidney donation? 77
Microwave Ablation of Renal Cell Carcinoma of the Transplanted Kidney : Two Cases 72
Clinical and Surgical Challenges in Kidney Transplantation: Toward a Personalized Approach? 70
3 Years Outcomes in a Randomized Trial Evaluating Everolimus Plus CNI Reduction in Kidney Transplant Recipients 69
Gonadal function and immunosuppressive therapy after renal transplantation 68
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-Year results of a pilot study 68
High-dose rituximab, plasma exchange with treated pooled human plasma, and aggressive monitoring of isoagglutinins in ABO incompatible kidney transplantation: 2-year results of a prospective trial 66
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study 66
Low Diagnostic Yield of Protocol Allograft Biopsy Performed During DGF in Deceased Donor Kidney Transplant Recipients Treated with Induction and Standard-Dose CNI-Based Maintenance 65
A prospective trial comparing tacrolimus with everolimus and low dose cyclosporine 64
Outcomes and surgical complications following living-donor renal transplantation using kidneys retrieved with trans-peritoneal or retro-peritoneal hand-assisted laparoscopic nephrectomy 62
Use of a single dose of basiliximab after major surgical procedures in kidney transplant recipients 60
Human polyomavirus 6 differentially infects healthy and tumor tissue in the colon: A case report 59
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 59
The Combination of Everolimus and Low Dose Cyclosporine Allows Similar Results as the Standard Tacrolimus and MMF Regimen: 3-Year Results of a Prospective Clinical Trial in Renal Transplant Recipients 59
MINI-INVASIVE LIVING DONOR NEPHRECTOMY USING THE HAND-ASSISTED LAPAROSCOPIC TECHNIQUE: OUR FIRST EXPERIENCE 59
Totale 13.196
Categoria #
all - tutte 50.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 0 0 0 0 0 0 0 0 81 92
2021/20221.136 47 55 22 14 41 170 43 178 115 70 101 280
2022/20231.411 154 106 149 132 156 287 36 63 136 18 131 43
2023/20241.266 39 66 36 113 302 141 71 50 24 49 185 190
2024/20252.992 99 351 60 293 215 171 129 290 185 262 336 601
2025/20266.578 559 442 693 526 534 389 768 293 805 398 1.171 0
Totale 15.235